A Universal Anti-Xa Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements: Method Validation, Diagnostic Accuracy and External Validation
Posted by Adam Awdish on
Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:
Guido Willekens, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Walter A. Wuillemin, Adrian Schmidt, Lukas Graf, Bernhard Gerber, Cedric Bovet, Thomas C. Sauter, and Michael Nagler
British Journal of Haematology
March 19, 2021
When it comes to medical treatments and emergency care, any treatment involving anticoagulants naturally carries the risk of increased bleeding. In fact, uncontrolled bleeding is the leading cause of death in trauma patients. Knowing the levels of anticoagulant drugs in the blood is essential to perform urgent surgery or planned thrombolysis. It is critical to determine a patient’s anticoagulant drug levels quickly and accurately in urgent medical settings.
Researchers in this study sought to develop a universal anti- Xa assay to detect rivaroxaban, apixaban and edoxaban drug concentrations in a patient.
Related products available from Innovative Research also include:
Single Donor Human Plasma (Blood Derived)